MCLAUGHLIN KEVIN F 4
4 · Vericel Corp · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Vericel CorpVCEL
MCLAUGHLIN KEVIN F
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-10$2.63/sh+7,000$18,410→ 22,100 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-10+7,000→ 10,500 totalExercise: $2.63Exp: 2027-05-03→ Common Stock (7,000 underlying) - Sale
Common Stock
2025-11-10$38.59/sh−7,000$270,130→ 15,100 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
- [F2]These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 3, 2017, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.